POSITIVE CHMP OPINION IN EU FOR SAXA/DAPA
May 27, 2016 07:53 ET | AstraZeneca PLC
POSITIVE CHMP OPINION IN EU FOR SAXA/DAPA (SAXAGLIPTIN AND DAPAGLIFLOZIN) FOR ADULTS WITH TYPE-2 DIABETES AstraZeneca today announced that the Committee for Medicinal Products for Human Use (CHMP) of...
download.jpg
IIROC Trade Resumption / L'OCRCVM permet la reprise de la negociation - MQR, MQR.WT.A VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 27, 2016) - Trading resumes in / Reprise des négociations pour: Company /...
Nautilus Minerals Chairman Retires
May 27, 2016 07:45 ET | Nautilus Minerals Inc.
TORONTO, ONTARIO--(Marketwired - May 27, 2016) - Nautilus Minerals Inc. (TSX:NUS)(OTCQX:NUSMF)(OTC:NUSMF Nasdaq Intl Designation) (the "Company" or "Nautilus") announces that Mr. A....
download.jpg
IIROC Trade Resumption / L'OCRCVM permet la reprise de la negociation - HLP.U VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 27, 2016) - Trading resumes in / Reprise des négociations pour : ...
Provision Holding Pr
Provision Holding Provides Quarterly Operational and Financial Results
May 27, 2016 07:30 ET | Provision Holding Inc.
CHATSWORTH, Calif., May 27, 2016 (GLOBE NEWSWIRE) -- Provision Holding, Inc. (OTCQB:PVHO) announced today operational and financial results for the fiscal quarter ended March 31, 2016. Total...
TGTX 2021 Logo
TG Therapeutics Enters into a Global Collaboration to Develop and Commercialize Novel BET Inhibitors Developed by Jubilant Biosys for the Treatment of Hematological Malignancies
May 27, 2016 07:30 ET | TG Therapeutics, Inc.
NEW YORK, May 27, 2016 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (Nasdaq:TGTX), announced today that as part of a broader agreement with Jubilant Biosys (“Jubilant”), an Indian...
checkpoint.jpg
Jubilant Biosys Enters into Exclusive out-Licensing Agreement with Checkpoint Therapeutics for Novel BET Inhibitors
May 27, 2016 07:30 ET | Checkpoint Therapeutics, Inc
NEW YORK and NOIDA (UP), India, May 27, 2016 (GLOBE NEWSWIRE) -- Jubilant Biosys Ltd (“Jubilant Biosys”), a subsidiary of Jubilant Life Sciences Ltd, and Checkpoint Therapeutics, Inc....
Aclaris_Logo_CLR®.jpg
Aclaris Therapeutics Announces $20.0 Million Private Placement
May 27, 2016 07:30 ET | Aclaris Therapeutics, Inc.
MALVERN, Pa., May 27, 2016 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a clinical-stage specialty pharmaceutical company, announced today that it has entered into a stock...
Gevo, Inc. Logo
Gevo to Attend Cowen and Company Annual Technology, Media & Telecom Conference on June 1, 2016
May 27, 2016 07:30 ET | Gevo, Inc.
ENGLEWOOD, Colo., May 27, 2016 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO) today announced that it will attend the Cowen and Company 44th Annual Technology, Media & Telecom Conference to be...
VIQ Solutions Reports First Quarter 2016 Results
May 27, 2016 07:28 ET | VIQ Solutions Inc.
MARKHAM, ONTARIO--(Marketwired - May 27, 2016) - VIQ Solutions Inc. ("VIQ Solutions" or the "Company") (TSX VENTURE:VQS), a global expert in secure digital media technology and services,...